COMMENTARY - THE STRATEGY AND VALUE OF NEUROLEPTIC DRUG-MONITORING

被引：44
作者：
CURRY, SH
机构：
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 1985年 / 5卷 / 05期
关键词：
D O I：
10.1097/00004714-198510000-00003
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：263 / 271
页数：9
相关论文
共 56 条
[51]   HALOPERIDOL, THIORIDAZINE AND PLACEBO IN MENTALLY SUBNORMAL PATIENTS - SERUM LEVELS AND CLINICAL EFFECTS [J].
VAISANEN, K ;
VIUKARI, M ;
RIMON, R ;
RAISANEN, P .
ACTA PSYCHIATRICA SCANDINAVICA, 1981, 63 (03) :262-271
[52]  
VANPUTTEN T, 1974, ARCH GEN PSYCHIAT, V31, P67
[53]   PLASMA-LEVELS OF THIOTHIXENE BY RADIORECEPTOR ASSAY - CLINICAL USEFULNESS [J].
VANPUTTEN, T ;
MAY, PRA ;
MARDER, SR ;
WILKINS, JN ;
ROSENBERG, BJ .
PSYCHOPHARMACOLOGY, 1983, 79 (01) :40-44
[54]   DOES A PLASMA-LEVEL OF CHLORPROMAZINE HELP [J].
VANPUTTEN, T ;
MAY, PRA ;
JENDEN, DJ .
PSYCHOLOGICAL MEDICINE, 1981, 11 (04) :729-734
[55]   CLINICAL EFFECTS AND DRUG CONCENTRATIONS IN PLASMA AND CEREBROSPINAL-FLUID IN PSYCHOTIC-PATIENTS TREATED WITH FIXED DOSES OF CHLORPROMAZINE [J].
WODEHELGODT, B ;
BORG, S ;
FYRO, B ;
SEDVALL, G .
ACTA PSYCHIATRICA SCANDINAVICA, 1978, 58 (02) :149-173
[56]  
1983, RECEPTOR N PACKAGE I
123456